SCHEMBL758549

SCHEMBL758549

CS(=O)(=O)c1nccc(Cl)n1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 6/20 0.37
MAPT P10636 6/20 0.37
TLR9 Q9NR96 5/20 0.37
NPC1 O15118 4/20 0.37
ALDH1A1 P00352 3/20 0.37
HTT P42858 3/20 0.37
NPSR1 Q6W5P4 3/20 0.37
XBP1 P17861 2/20 0.37
MAPK1 P28482 2/20 0.37
HSD17B10 Q99714 1/20 0.37
PARP1 P09874 1/20 0.37
LMNA P02545 4/20 0.35
SMN1; SMN2 Q16637 3/20 0.35
RAB9A P51151 4/20 0.34
MITF O75030 2/20 0.34
S1PR4 O95977 1/20 0.34
PKM P14618 1/20 0.34
PAX8 Q06710 1/20 0.34
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31206017 0.79 CA12 (0.41) NPC1ALDH1A1HTTNPSR1LMNA
SCHEMBL4138614 0.77 NPSR1 (0.42) TP53MAPTTLR9NPC1ALDH1A1
SCHEMBL30637352 0.77 NPSR1 (0.42) TP53MAPTTLR9NPC1ALDH1A1
SCHEMBL1750195 0.77 PARP1 (0.38) TP53MAPTTLR9NPC1ALDH1A1
SCHEMBL11127281 0.76 NFE2L2 (0.32) ALDH1A1MEN1KMT2A
SCHEMBL27828077 0.76 LMNA (0.36) TP53MAPTTLR9NPC1ALDH1A1
SCHEMBL6430723 0.76 USP2 (0.41) TP53MAPTTLR9NPC1ALDH1A1
SCHEMBL22471636 0.75 PARP1 (0.37) TP53MAPTTLR9NPC1ALDH1A1
SCHEMBL20606050 0.75 LMNA (0.39) TP53MAPTTLR9NPC1ALDH1A1
SCHEMBL1490042 0.75 MTOR (0.37) MAPTPARP1LMNASMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 391 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3658552-B1 PROCESS FOR PREPARING N-(5-((4-(4-((DIMETHYLAMINO)METHYL)-3-PHENYL-1H-PYRAZOL-1-YL)PYRIMIDIN-2-YL)AMINO)-4-METHOXY-2-MORPHOLINOPHENYL)ACRYLAMIDE BY REACTING THE CORRESPONDING AMINE WITH A 3-HALO-PROPIONYL CHLORIDE YUHAN CORP (KR) 2023-09-13 EP claimed
CN-111315742-B Process for preparing aminopyrimidine derivatives 株式会社 柳韩洋行 2023-09-01 CN claimed
US-11286253-B2 Process for preparing aminopyrimidine derivatives YUHAN CORPORATION (KR) 2022-03-29 US claimed
US-10889578-B2 Process for preparing aminopyrimidine derivatives YUHAN CORPORATION (KR) 2021-01-12 US claimed
CN-111315742-A Improved process for preparing aminopyrimidine derivatives 株式会社柳韩洋行 2020-06-19 CN claimed
EP-3658552-A1 IMPROVED PROCESS FOR PREPARING AMINOPYRIMIDINE DERIVATIVES Yuhan Corporation (KR) 2020-06-03 EP claimed
US-20200165236-A1 IMPROVED PROCESS FOR PREPARING AMINOPYRIMIDINE DERIVATIVES YUHAN CORPORATION (KR) 2020-05-28 US claimed
WO-2019022485-A1 IMPROVED PROCESS FOR PREPARING AMINOPYRIMIDINE DERIVATIVES YUHAN CORPORATION (KR) 2019-01-31 WO claimed
EP-4746963-A1 MACROCYCLES FOR THE TREATMENT OF AUTOIMMUNE DISEASE F. Hoffmann-La Roche AG (CH) 2026-05-27 EP disclosed
EP-4743465-A1 BICYCLIC MACROCYCLES FOR THE TREATMENT OF AUTOIMMUNE DISEASE F. Hoffmann-La Roche AG (CH) 2026-05-20 EP disclosed
CN-122039076-A Preparation method of 2-methyl sulfoxide pyrimidine derivative 石河子大学 2026-05-15 CN disclosed
EP-4725554-A2 COMPOUNDS AND COMPOSITIONS FOR MODULATING EGFR MUTANT KINASE ACTIVITIES Yuhan Corporation (KR) 2026-04-15 EP disclosed
EP-4709723-A1 ISOXAZOLIDINES AS RIPK1 INHIBITORS AND USE THEREOF GENZYME CORPORATION (US) 2026-03-18 EP disclosed
US-20260070927-A1 INDAZOLE MACROCYCLES FOR THE TREATMENT OF AUTOIMMUNE DISEASE HOFFMANN-LA ROCHE INC. (US) 2026-03-12 US disclosed
US-4118382-A DYES FOR CELLULOSE, WOOL, SILK, POLYAMIDE, AND POLYURETHANE FIBERS BAYER AKTIENGESELLSCHAFT (DE) 1978-10-03 US disclosed
US-4089895-A COUPLER FOR AZO DYES BAYER AKTIENGESELLSCHAFT (DT) 1978-05-16 US disclosed
US-4065446-A Reactive dyestuffs containing urea alkylene linkage between chromophore and reactive radical BAYER AKTIENGESELLSCHAFT (DT) 1977-12-27 US disclosed
US-4049704-A AZO REACTIVE DYES BAYER AKTIENGESELLSCHAFT (DT) 1977-09-20 US disclosed
US-3988310-A FIBER-REACTIVE DYES; CELLULOSE BAYER AKTIENGESELLSCHAFT (DT) 1976-10-26 US disclosed
US-3957751-A WATER-SOLUBLE REACTIVE DYESTUFFS OF THE MONOAZO SERIES CONTAINING AN ACTIVE METHYLENE COUPLING COMPONENT HOECHST AKTIENGESELLSCHAFT (DT) 1976-05-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200165236-A1 IMPROVED PROCESS FOR PREPARING AMINOPYRIMIDINE DERIVATIVES EGFR, ERBB2, ERBB4 TP53 247/4885MAPT 3545/4885TLR9 3449/4885
US-11286253-B2 Process for preparing aminopyrimidine derivatives EGFR, ERBB2, ABL1 TP53 207/4885MAPT 3799/4885TLR9 3593/4885
US-20260070927-A1 INDAZOLE MACROCYCLES FOR THE TREATMENT OF AUTOIMMUNE DISEASE MALT1, CCR1, CCR6 TP53 2738/4885MAPT 4693/4885TLR9 2330/4885
US-10889578-B2 Process for preparing aminopyrimidine derivatives EGFR, ERBB2, ABL1 TP53 218/4885MAPT 3689/4885TLR9 3421/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.